Search clinical trials for: SL-172154

Total 569 results

Johns Hopkins University

Terminated

CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies (FIRST-STIM)

Inflammatory Myelopathies

United States
Waldemar Link GmbH & Co. KG

Active, not recruiting

Clinical and Functional Outcome of the Gemini SL Fixed Bearing at Midterm Follow-up

Total Knee Replacement

Germany, Spain
Hutchmed

Active, not recruiting

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Lymphoma

Spain, United States, France, Italy, Finland, Poland
University of Kansas Medical Center
The Leukemia and Lymphoma Society; Kansas Bioscience Authority; Therapeutics...

Completed

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

Leukemia, Prolymphocytic | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma

United States
CREA Medicina de la Reproducción SL

Recruiting

Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate (IS-MFluidics)

Intracytoplasmic Sperm Injection | Sperm | Microfluidics

Spain
Universidad Complutense de Madrid
NORICUM SL

Recruiting

Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral (PROTEOGRAFT)

Edentulous Alveolar Ridge | Alveolar Bone Loss | Loss of Teeth Due to Extraction

Spain
Ability Pharmaceuticals SL
The Cleveland Clinic

Suspended

A Study of ABTL0812 in Pancreatic Cancer (Pancreatic)

Pancreatic Cancer

Spain
Clinica Francisco Ortega Rehabilitacion Avanzada...

Completed

Effects of Percutaneous Neuromodulation on Plasticity in the Somatosensory System in Healthy Subjects

Healthy

Spain
Pyramid Biosciences

Completed

A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants

Healthy Volunteers

United States
M.D. Anderson Cancer Center
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
Adacyte Therapeutics SL
Adknoma Health Research

Recruiting

CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis

Ulcerative Colitis

Spain, Portugal
Universidad Complutense de Madrid
Dentaid SL

Completed

Impact of a Newly Formulated Toothpaste in Tooth Staining Associated With Chlorhexidine Rinses (PaSTaining)

Periodontitis | Tooth Staining

Spain
Universidad Complutense de Madrid
Dentaid SL

Completed

Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis

Peri-implant Mucositis

Spain
Universitat Internacional de Catalunya
Dentaid SL

Completed

Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.

Dental Plaque | Side Effects

Spain
H. Lee Moffitt Cancer Center and Research Institute
Novartis; Celgene Corporation

Active, not recruiting

Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
National Heart, Lung, and Blood Institute (NHLBI)
GlaxoSmithKline; University of Virginia

Completed

Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL

Small Lymphocytic Lymphoma | CLL (Chronic Lymphocytic Leukemia)

United States
Pharmacotherapies for Alcohol and Substance Use...
United States Department of Defense; RTI International

Terminated

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

Post Traumatic Stress Disorder | Alcohol Abuse

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma (VCR)

Lymphoma | Mantle Cell Lymphoma | Indolent Lymphoma | SLL

United States
Sun Yat-sen University

Not yet recruiting

A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant

Locally Advanced Unresectable Gastric Cancer

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Zhongshan People's Hospital... and other collaborators

Recruiting

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) (EC-CRT-002)

Esophageal Squamous Cell Carcinoma | Locally Advanced Esophageal Squamous Cell Carcinoma

China
Sun Yat-sen University

Recruiting

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Colorectal Cancer Liver Metastases

China
Sun Yat-sen University

Completed

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Primary Malignant Melanoma of the Esophagus

China
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Jacobs University Bremen gGmbH
Guangdong Provincial People's Hospital; Maastricht University; Hong Kong Baptist... and other collaborators

Completed

Web-based Aftercare Intervention for Cardiac Patients (RENATA)

CARDIOVASCULAR DISEASES | HEART DISEASES

China, Germany, Netherlands
Medical Research Foundation, The Netherlands
Langerhans Foundation, the Netherlands

Completed

Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin

Diabetes Mellitus, Type 2

Netherlands
Medical Research Foundation, The Netherlands
Netherlands: Ministry of Health, Welfare and Sports; Langerhans Foundation,...

Completed

The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Netherlands
Pfizer

Completed

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung (NSCLC)

Ukraine, Poland, Romania, South Africa
Tonix Pharmaceuticals, Inc.
Premier Research Group plc

Terminated

Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD (HONOR)

PTSD

United States
Wake Forest University Health Sciences

Withdrawn

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Opioid Use
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Stress Management Training for Latinas Receiving Chemotherapy

Cancer | Stress

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
Memorial Sloan Kettering Cancer Center
Pharmacyclics LLC.

Withdrawn

A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLL

United States
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (RESONATE™)

Relapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Leukemia

United States, Poland
TruDiagnostic
Circadian Wellness Corp

Not yet recruiting

Clinical Efficacy of a Supplement on Sleep Quality

Sleep
Fujun Zhang

Recruiting

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma (RAFAS-001)

Sarcoma,Soft Tissue | Brachytherapy | Poly(ADP-ribose) Polymerase Inhibitors

China
Sun Yat-sen University

Recruiting

Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

China
Ege University

Completed

Additional Circular Dressing Material

Nurse's Role

Turkey
Junling Li

Unknown

The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer

Apatinib in Maintenance Treatment

China
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Sanofi

Completed

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

Prostatic Hyperplasia | Acute Urinary Retention
AbbVie

Not yet recruiting

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
BeiGene

Completed

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia (ALPINE)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Poland
Genzyme, a Sanofi Company

Completed

Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

United States
Topcon Medical Systems, Inc.

Withdrawn

Non-Invasive Imaging of the Human Eye

Willing and Able Subjects for Ocular Imaging

United States
Ruijin Hospital

Unknown

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Ovarian Cancer | Endometrial Cancer

China
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

AI-Based Imaging Model for Bladder Cancer Prediction

Develop a CT-based Tumor Budding Predictive Model for Bladder Cancer Using Deep Learning Algorithms

China
Sun Yat-sen University
Hutchmed; BeiGene

Not yet recruiting

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Metastatic Colorectal Cancer | mCRC

China
Sun Yat-sen University
Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaborators

Recruiting

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Not yet recruiting

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Non Clear Cell Renal Carcinoma

China

Search clinical trials for: SL-172154

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations